氯胺酮诱导人iPSC来源神经元的突触与单胺能重塑
Ketamine induces synaptic and monoaminergic remodeling in human iPSC-derived neurons
一项发表于Translational Psychiatry的研究显示,氯胺酮(1 µM,处理72小时)可显著增加人iPSC来源前脑神经元突触后支架蛋白PSD-95的突触定位,并选择性调控Akt通路,但不改变BDNF蛋白水平或MAPK激活。
- Article
- Open access
- Published: 16 October 2026
- Jessica Pagano1 na1,
- Eleonora Mangano2 na1,
- Sofia Eminente1,
- Matteo Marcatili ORCID: orcid.org/0000-0002-1436-19613,
- Michaela Krivosova4,
- Matteo Colombo1,
- Viviana Tritto5,
- Roberta Bordoni2,
- Tobias M. Boeckers ORCID: orcid.org/0000-0002-1486-85356,7,
- Luciano Conti ORCID: orcid.org/0000-0002-2050-98468 &
- …
- Carlo Sala ORCID: orcid.org/0000-0003-0662-95231,9
Translational Psychiatry (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Major depressive disorder (MDD) is a leading cause of global disability, and a substantial proportion of patients develop treatment-resistant depression (TRD), highlighting the urgent need for mechanistically novel and fast-acting antidepressants. Ketamine has emerged as a paradigm-shifting therapy due to its rapid and robust antidepressant effects, yet its molecular mechanisms in human neurons remain incompletely understood. Here, we investigated the cellular and transcriptomic effects of ketamine in human induced pluripotent stem cell (hiPSC)-derived forebrain neurons. Neuronal cultures were treated with ketamine (1 µM) for 72 h and analyzed using immunocytochemistry, western blotting, and RNA sequencing. Ketamine treatment did not alter gross neuronal morphology or presynaptic organization but significantly increased synaptic localization of the postsynaptic scaffolding protein PSD-95, suggesting molecular changes associated with synaptic remodeling. At the signaling level, ketamine selectively modulated the Akt pathway without inducing changes in BDNF protein levels or MAPK activation, and without broadly altering excitatory or inhibitory synaptic protein expression. Transcriptomic profiling revealed 604 differentially expressed genes, with significant enrichment of pathways related to serotonergic and dopaminergic neurotransmission. Notably, ketamine upregulated genes involved in monoamine synthesis and signaling, including DDC and DRD1, while downregulating genes associated with GPCR ligand binding and neurotransmitter transport. SynGO analysis further identified selective regulation of synapse-associated genes, predominantly affecting presynaptic and neurotransmitter uptake mechanisms. Together, these findings indicate that ketamine induces molecular and transcriptional changes in human neurons that are consistent with synaptic remodeling and with activation of transcriptional programs enriched for monoaminergic signaling pathways. This hiPSC-based model provides a platform to investigate the molecular responses of human neurons to ketamine and to explore patient-specific mechanisms in future studies.
Acknowledgements
We thank Prof. Laura Musazzi (University of Milano-Bicocca) for kindly providing some of the reagents used in this study and Alessia Stefanoni for her contribution to the preliminary experiments.
Funding
This work was supported by Italian Cariplo Foundation (grant 2019-3396) to C.S. and L.C., by the Jerome Lejeune (project #1638) and by the Telethon Fondazione Onlus (GRM22T1610) to C.S.
Author information
Author notes
These authors contributed equally: Jessica Pagano, Eleonora Mangano.
Authors and Affiliations
CNR Institute of Neuroscience, Milano, 20854, Vedano al Lambro, Italy
Jessica Pagano, Sofia Eminente, Matteo Colombo & Carlo Sala
CNR Institute for Biomedical Technologies, 20054, Segrate, Italy
Eleonora Mangano & Roberta Bordoni
Department of Mental Health, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS) San Gerardo dei Tintori, 20090, Monza, Italy
Matteo Marcatili
Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, 81101, Bratislava, Slovakia
Michaela Krivosova
Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, 20122, Milan, Italy
Viviana Tritto
Institute for Anatomy and Cell Biology, Ulm University, Ulm, Germany
Tobias M. Boeckers
Ulm Site, DZNE, Ulm, Germany
Tobias M. Boeckers
Laboratory of Stem Cell Biology, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, 38123, Trento, Italy
Luciano Conti
Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS), San Gerardo dei Tintori, 20090, Monza, Italy
Carlo Sala
Authors
- Jessica Pagano
- Eleonora Mangano
- Sofia Eminente
- Matteo Marcatili
- Michaela Krivosova
- Matteo Colombo
- Viviana Tritto
- Roberta Bordoni
- Tobias M. Boeckers
- Luciano Conti
- Carlo Sala
Corresponding author
Correspondence to Carlo Sala.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics
The study was performed using previously established human induced pluripotent stem cell (iPSC) lines [14, 33]. No new human samples were collected, and no participants were recruited for this study. Therefore, no additional ethical approval was required for the experiments reported in this manuscript.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pagano, J., Mangano, E., Eminente, S. et al. Ketamine induces synaptic and monoaminergic remodeling in human iPSC-derived neurons. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04525-1
Received: 11 March 2026
Revised: 09 September 2026
Accepted: 01 October 2026
Published: 16 October 2026
DOI: https://doi.org/10.1038/s41398-026-04525-1
来源:Nature 干细胞主题 · nature.com